Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VISX is a pioneering medical device company that revolutionized the field of ophthalmology through the development of excimer laser systems for vision correction. The company is best known for its role in the development and commercialization of LASIK (Laser-Assisted In Situ Keratomileusis) and PRK (Photorefractive Keratectomy) technologies. Its flagship product, the STAR S4 IR Excimer Laser System, utilizes advanced wavefront-guided technology to provide highly precise treatments for myopia, hyperopia, and astigmatism. Originally an independent public company, VISX was acquired by Advanced Medical Optics in 2005 and is now a key part of the Johnson & Johnson Vision portfolio. The VISX platform remains one of the most widely used laser vision correction systems globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VISX.